1-8 of 8
Yan Jin
Close
Sort by
Journal Articles

HAP1 loss confers l-asparaginase resistance in ALL by downregulating the calpain-1-Bid-caspase-3/12 pathway

CME
Jung Kwon Lee, SungMyung Kang, Xidi Wang, Jesusa L. Rosales, Xu Gao, Hee-Guk Byun, Yan Jin, Songbin Fu, Jinghua Wang, Ki-Young Lee
Journal: Blood
Blood (2019) 133 (20): 2222–2232.
https://doi.org/10.1182/blood-2018-12-890236
Published: 2019
Includes: Supplemental data
Journal Articles

PTENα promotes neutrophil chemotaxis through regulation of cell deformability

Yunqiao Li, Yuan Jin, Bowen Liu, Dan Lu, Minglu Zhu, Yan Jin, Michael A. McNutt, Yuxin Yin
Journal: Blood
Blood (2019) 133 (19): 2079–2089.
https://doi.org/10.1182/blood-2019-01-899864
Published: 2019
Includes: Multimedia, Supplemental data
Journal Articles

Exposure-Response Analysis to Assist Selection of Dose and Treatment Duration for Polatuzumab Vedotin As a Single Agent or in Combination with Rituximab for the Treatment of B-Cell Lymphoma

Dan Lu, Jin Yan Jin, Leonid Gibiansky, William R. Gillespie, Priya Agarwal, Cheryl Jones, Yu-Waye Chu, Michael K. Wenger, Jamie Hirata, Chunze Li, Sandhya Girish
Journal: Blood
Blood (2015) 126 (23): 1525.
https://doi.org/10.1182/blood.V126.23.1525.1525
Published: 2015
Journal Articles

Targeted nanoparticle delivery overcomes off-target immunostimulatory effects of oligonucleotides and improves therapeutic efficacy in chronic lymphocytic leukemia

Bo Yu, Yicheng Mao, Li-Yuan Bai, Sarah E. M. Herman, Xinmei Wang, Asha Ramanunni, Yan Jin, Xiaokui Mo, Carolyn Cheney, Kenneth K. Chan, David Jarjoura, Guido Marcucci, Robert J. Lee, John C. Byrd, L. James Lee, Natarajan Muthusamy
Journal: Blood
Blood (2013) 121 (1): 136–147.
https://doi.org/10.1182/blood-2012-01-407742
Published: 2013
Includes: Supplemental data
Journal Articles

Therapeutic Targeting of the RAS-Pathway by Synthetic Mir-181a Nanoparticles in Acute Myeloid Leukemia (AML).

Xiaomeng Huang, Sebastian Schwind, MD, Ann-Kathrin Eisfeld, MD, Bo Yu, Ph.D, Ramasamy Santhanam, Ph.D, Pia Hoellerbauer, Yan Jin, Ph.D, Christopher Hickey, Ph.D, Jiuxia Pang, Kenneth K. Chan, Ph.D, Danilo Perrotti, MD, Ph.D, Natarajan Muthusamy, DVM, Ph.D, John C. Byrd, MD, William Blum, MD, Clara D. Bloomfield, MD, Shujun Liu, Ph.D, Ramiro Garzon, MD, Robert J. Lee, Ph.D, L. James Lee, Ph.D, Guido Marcucci, MD
Journal: Blood
Blood (2012) 120 (21): 2422.
https://doi.org/10.1182/blood.V120.21.2422.2422
Published: 2012
Journal Articles

Epigenetic inactivation of the MIR34B/C in multiple myeloma

Brief Report
Kwan Yeung Wong, Rita Lok Hay Yim, Chi Chiu So, Dong-Yan Jin, Raymond Liang, Chor Sang Chim
Journal: Blood
Blood (2011) 118 (22): 5901–5904.
https://doi.org/10.1182/blood-2011-06-361022
Published: 2011
Includes: Supplemental data
Journal Articles

Liposomal Targeted Delivery Overcomes Immunostimulatory Effects of Oligonucleotide Based Therapy In Chronic Lymphocytic Leukemia.

Bo Yu, Yicheng Mao, Li-Yuan Bai, Sarah E.M. Herman, Asha Ramanunni, Yan Jin, Xiaokui Mo, PhD, Carolyn Cheney, Kenneth K. Chan, PhD, David Jarjoura, Guido Marcucci, MD, Robert Lee, L.James Lee, John C. Byrd, MD, Natarajan Muthusamy, DVM, PhD
Journal: Blood
Blood (2010) 116 (21): 1475.
https://doi.org/10.1182/blood.V116.21.1475.1475
Published: 2010
Journal Articles

Identification and characterization of EBP, a novel EEN binding protein that inhibits Ras signaling and is recruited into the nucleus by the MLL-EEN fusion protein

Judy Wai Ping Yam, Dong-Yan Jin, Chi Wai So, Li Chong Chan
Journal: Blood
Blood (2004) 103 (4): 1445–1453.
https://doi.org/10.1182/blood-2003-07-2452
Published: 2004